Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Close

Johnson & Johnson (JNJ)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
162.40 +2.83    +1.77%
18/09 - Closed. Currency in USD ( Disclaimer )
  • Volume: 7
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 162.40 - 162.40
Type:  Equity
Market:  Peru
ISIN:  US4781601046 
S/N:  JNJ
J&J 162.40 +2.83 +1.77%

NYSE:JNJ Financials

 
See below for an overview of the Johnson & Johnson financial reports. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track the NYSE:JNJ financials over time.

Johnson & Johnson reported earnings results for the second quarter and six months ended July 02, 2023. For the second quarter, the company reported sales was USD 25,530 million compared to USD 24,020 million a year ago. Net income was USD 5,144 million compared to USD 4,814 million a year ago. Diluted earnings per share from continuing operations was USD 1.96 compared to USD 1.8 a year ago.For the six months, sales was USD 50,276 million compared to USD 47,446 million a year ago. Net income was USD 5,076 million compared to USD 9,963 million a year ago. Diluted earnings per share from continuing operations was USD 1.93 compared to USD 3.73 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

JNJ Income Statement

Gross margin TTM 67.5%
Operating margin TTM 27.66%
Net Profit margin TTM 13.35%
Return on Investment TTM 20.37%
 Total Revenue  Net Income
Period Ending: Jul 02, 2023 Apr 02, 2023 Jan 01, 2023 Oct 02, 2022
Total Revenue 25530 24746 23706 23791
Gross Profit 17518 16551 15995 15997
Operating Income 7382 7201 5928 6598
Net Income 5144 -68 3520 4458

JNJ Balance Sheet

Quick Ratio MRQ 0.84
Current Ratio MRQ 1.12
LT Debt to Equity MRQ 45.11%
Total Debt to Equity MRQ 60.68%
 Total Assets  Total Liabilities
Period Ending: Jul 02, 2023 Apr 02, 2023 Jan 01, 2023 Oct 02, 2022
Total Assets 191686 195969 187378 175124
Total Liabilities 115277 125100 110574 100525
Total Equity 76409 70869 76804 74599

JNJ Cash Flow Statement

Cash Flow/Share TTM 7.34
Revenue/Share TTM 37.62
Operating Cash Flow  7.72%
 Cash  Net Change in Cash
Period Ending: Jul 02, 2023 Apr 02, 2023 Jan 01, 2023 Oct 02, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 4182 3257 5350 6284
Cash From Investing Activities -3776 3315 -4397 -1701
Cash From Financing Activities -5991 6138 1700 -3925
Net Change in Cash -5682 12738 2772 372
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

JNJ Comments

Write your thoughts about Johnson & Johnson
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andre Van Laer
Andre Van Laer Aug 25, 2023 20:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Kenvur buyers return to jnj? Double discount/double dip...? LOL?
Reply
0 0
Report
Nik Daniel
Nik Daniel Feb 18, 2023 7:43
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Niceee movement
Reply
0 0
Report
Lee Baldwin
Lee Baldwin Aug 24, 2022 15:50
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Interest rates?
Reply
0 0
Report
ifigeneia ifigeneia
ifigeneia ifigeneia Oct 15, 2021 16:00
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
FDA approved finally. Few minutes ago!!!!
Reply
2 0
Report
Lee Baldwin
Lee Baldwin Oct 15, 2021 16:00
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What?
Reply
0 0
Report
Lukas Bednall
Lukas Bednall Sep 22, 2021 19:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
Reply
3 0
Report
ifigeneia ifigeneia
ifigeneia ifigeneia Sep 22, 2021 19:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
To entry in Spectrum or not? What do you think?
Reply
0 0
Report
Adam Whipps
Adam Whipps Sep 22, 2021 19:15
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Checking it out looks like a good punt
Reply
0 0
Report
Oc Masai
Oc Masai Apr 24, 2021 11:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good job JNJ. move forward bullish
Reply
2 0
Report
Lee Baldwin
Lee Baldwin Dec 29, 2020 15:31
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Stock split???
Reply
0 0
Report
Sinisa Galesic
Sinisa Galesic Dec 22, 2020 23:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Where we go next?
Reply
0 0
Report
Paul Strong
Paul Strong Dec 22, 2020 23:01
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
AMC! But ultimately it’s your decision.
Reply
0 0
Report
Lee Baldwin
Lee Baldwin Oct 29, 2020 16:12
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Good buy. 0at this price
Reply
3 0
Report
AdrianQ Khew
AdrianQ Khew Jul 23, 2019 11:10
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
JNJ is going to Make a strong come back tonight!
Reply
4 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email